Healthcare provider profile · identity verified

David Johansen, M.D.

Internal Medicine · GRAND JUNCTION, CO · NPI 1114248465

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	634	187
Levothyroxine Sodium	Levothyroxine Sodium	386	92
Amlodipine Besylate	Amlodipine Besylate	339	97
Hydrochlorothiazide	Hydrochlorothiazide	291	88
Lisinopril	Lisinopril	281	82
Losartan Potassium	Losartan Potassium	249	77
Pantoprazole Sodium	Pantoprazole Sodium	205	59
Omeprazole	Omeprazole	179	58
Metoprolol Succinate	Metoprolol Succinate	162	47
Tamsulosin Hcl	Tamsulosin Hcl	161	50
Furosemide	Furosemide	158	46
Eliquis	Apixaban	146	42
Gabapentin	Gabapentin	146	38
Rosuvastatin Calcium	Rosuvastatin Calcium	142	46
Alendronate Sodium	Alendronate Sodium	130	44
Alprazolam	Alprazolam	101	27
Jardiance	Empagliflozin	98	22
Donepezil Hcl	Donepezil Hcl	95	25
Metformin Hcl	Metformin Hcl	85	28
Duloxetine Hcl	Duloxetine Hcl	77	21
Spironolactone	Spironolactone	77	26
Trazodone Hcl	Trazodone Hcl	77	28
Simvastatin	Simvastatin	69	21
Carvedilol	Carvedilol	68	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	68	19
Potassium Chloride	Potassium Chloride	68	21
Sertraline Hcl	Sertraline Hcl	68	15
Venlafaxine Hcl Er	Venlafaxine Hcl	66	16
Fluoxetine Hcl	Fluoxetine Hcl	65	21
Oxycodone Hcl	Oxycodone Hcl	63	13
Allopurinol	Allopurinol	62	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	19
Metformin Hcl Er	Metformin Hcl	59	16
Tramadol Hcl	Tramadol Hcl	59	15
Lorazepam	Lorazepam	57	15
Mirtazapine	Mirtazapine	57	14
Zolpidem Tartrate	Zolpidem Tartrate	57	25
Pravastatin Sodium	Pravastatin Sodium	55	16
Pregabalin	Pregabalin	55	19
Doxazosin Mesylate	Doxazosin Mesylate	51	16
Mounjaro	Tirzepatide	49	suppressed
Clopidogrel	Clopidogrel Bisulfate	48	suppressed
Fluticasone Propionate	Fluticasone Propionate	44	17
Bupropion Xl	Bupropion Hcl	42	13
Celecoxib	Celecoxib	42	18
Escitalopram Oxalate	Escitalopram Oxalate	42	13
Farxiga	Dapagliflozin Propanediol	41	suppressed
Enalapril Maleate	Enalapril Maleate	39	12
Finasteride	Finasteride	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	14
Gemtesa	Vibegron	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	11
Propranolol Hcl Er	Propranolol Hcl	38	11
Estradiol	Estradiol	36	16
Albuterol Sulfate Hfa	Albuterol Sulfate	35	14
Citalopram Hbr	Citalopram Hydrobromide	35	11
Metoprolol Tartrate	Metoprolol Tartrate	35	suppressed
Prednisone	Prednisone	35	26
Diclofenac Sodium Er	Diclofenac Sodium	34	16
Memantine Hcl	Memantine Hcl	34	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Azithromycin	Azithromycin	30	30
Warfarin Sodium	Warfarin Sodium	30	11
Paxlovid	Nirmatrelvir/Ritonavir	28	28
Valacyclovir	Valacyclovir Hcl	28	18
Ozempic	Semaglutide	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Atenolol	Atenolol	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Prolia	Denosumab	25	16
Synthroid	Levothyroxine Sodium	25	suppressed
Bumetanide	Bumetanide	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	17
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	21
Valsartan	Valsartan	23	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	19
Clonazepam	Clonazepam	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Myrbetriq	Mirabegron	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Amoxicillin	Amoxicillin	19	15
Chlorthalidone	Chlorthalidone	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Diazepam	Diazepam	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Cephalexin	Cephalexin	17	13
Primidone	Primidone	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Ramipril	Ramipril	15	suppressed
Testosterone	Testosterone	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Estradiol (Twice Weekly)	Estradiol	14	suppressed
Famotidine	Famotidine	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Naproxen	Naproxen	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Risedronate Sodium	Risedronate Sodium	13	suppressed
Torsemide	Torsemide	13	suppressed
Wegovy	Semaglutide	13	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	11	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error